Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

favicon.ico

favicon-16x16.png

favicon-32x32.png

apple-touch-icon.png

MoFo Favicons

Terms / Notices

Cookies

Privacy Policy

Attorney Advertising

Secure Login

Alumni

  Facebook

MoFo Facebook

  Linkedin

MoFo LinkedIN

Twitter

MoFo Twitter

YouTube

MoFo Youtube

Morrison Foerster - Footer

You have not solved the recaptcha challenge yet or session expired, try again.

Disclaimer

<p>Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html"><u><em>Privacy Policy</em></u></a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.</p>

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

Our lawyers, who counsel public companies and their boards of directors in all aspects of regulatory compliance, provide their insights on the latest developments in regards to securities disclosures and compliance with government and stock exchange requirements in light of the coronavirus (COVID-19) pandemic.
 
Client Alerts

Coronavirus (COVID-19): U.S. SEC Staff Statements on Public Company Disclosure and Financial Reporting, 1 July 2020
Coronavirus (COVID-19): U.S. SEC and States Provide Further Relief for Upcoming Annual Shareholder Meetings, 17 April 2020
Coronavirus (COVID-19): Liability Management Considerations, 16 April 2020
Coronavirus (COVID-19): ISS and Glass Lewis Adopt Policy Changes for the 2020 Proxy Season, 14 April 2020
SEC Staff Guidance Regarding the Filing of Form 144 in Light of COVID-19, 13 April 2020
COVID-19: SEC Statements on Public Company Disclosure and Financial Reporting, 12 April 2020
Coronavirus (COVID-19) and Stock Repurchase Programs, 2 April 2020
Coronavirus (COVID-19): Preparing for Form 8-K Disclosures, 1 April 2020
Coronavirus (COVID-19): Dealing with Customers in Financial Distress, 31 March 2020
SEC Eases Compliance with Form ID, Regulation A, and Regulation Crowdfunding Requirements, 30 March 2020
SEC Extends Conditional Exemptions for Exchange Act Filings and Proxy Materials, 26 March 2020
Guidance for Public Companies on Signatures and Disclosure Considerations in Light of COVID-19, 26 March 2020
COVID-19: Liquidity Issues and Debt Incurrence Capacity in High Yield Bonds, 26 March 2020
Coronavirus (COVID-19) Considerations for Shareholder Proposals, 23 March  2020
Coronavirus (COVID-19): How Delays in Processing of Filings May Impact Transactions, 20 March  2020
COVID-19 (Coronavirus): A Practical Checklist for Directors, 19 March  2020
SEC Guidance on Annual Meeting Changes Due to COVID-19, 18 March  2020
What Companies Need to Know Now About Public Disclosures Concerning COVID-19, 17 March  2020
COVID-19 and Rule 10b5-1 Plans: Best Practices, 16 March  2020
Disclosure and Governance Hot Topics for Public Companies in 2020, 25 Feb  2020


Press + News

Practical Tips for Virtual Oversights (Article), 1 April 2020
So Your Company’s CEO Has Coronavirus. Does the World Have to Know? (Article), 25 March 2020
Why In-House Counsel Need to Watch for Insider Trading, Public Disclosure Issues From COVID-19 (Article), 11 March 2020


Coronavirus (COVID-19) Public Companies

<p>Our lawyers, who counsel public companies and their boards of directors in all aspects of regulatory compliance, provide their insights on the latest developments in regards to securities disclosures and compliance with government and stock exchange requirements in light of the coronavirus (COVID-19) pandemic.</p> <h4>Client Alerts</h4><ul><li><a href="/resources/insights/200701-covid-19-sec-public-company-disclosure">Coronavirus (COVID-19): U.S. SEC Staff Statements on Public Company Disclosure and Financial Reporting, 1 July 2020</a></li><li><a href="/resources/insights/200417-us-sec-relief-covid-19">Coronavirus (COVID-19): U.S. SEC and States Provide Further Relief for Upcoming Annual Shareholder Meetings, 17 April 2020</a></li><li><a href="/resources/insights/200416-liability-management-covid-19">Coronavirus (COVID-19): Liability Management Considerations, 16 April 2020</a></li><li><a href="/resources/insights/200414-coronavirus-covid-19-iss-glass-lewis-2020-proxy-season">Coronavirus (COVID-19): ISS and Glass Lewis Adopt Policy Changes for the 2020 Proxy Season, 14 April 2020</a></li><li><a href="/resources/insights/200413-sec-guidance-form-144-covid-19">SEC Staff Guidance Regarding the Filing of Form 144 in Light of COVID-19, 13 April 2020</a></li><li><a href="/resources/insights/200412-covid-19-sec-statements-on-disclosure-and-reporting">COVID-19: SEC Statements on Public Company Disclosure and Financial Reporting, 12 April 2020</a></li><li><a href="/resources/insights/200402-covid-19-and-stock-repurchase-programs">Coronavirus (COVID-19) and Stock Repurchase Programs, 2 April 2020</a></li><li><a href="/resources/insights/200401-preparing-form-8-k-disclosures">Coronavirus (COVID-19): Preparing for Form 8-K Disclosures, 1 April 2020</a></li><li><a href="/resources/insights/200331-customers-financial-distress">Coronavirus (COVID-19): Dealing with Customers in Financial Distress, 31 March 2020</a></li><li><a href="/resources/insights/200330-sec-eases-compliance">SEC Eases Compliance with Form ID, Regulation A, and Regulation Crowdfunding Requirements, 30 March 2020</a></li><li><a href="/resources/insights/200326-sec-extends-conditional-exemptions">SEC Extends Conditional Exemptions for Exchange Act Filings and Proxy Materials, 26 March 2020</a></li><li><a href="/resources/insights/200326-signatures-and-disclosure-considerations-in-light-of-covid-19">Guidance for Public Companies on Signatures and Disclosure Considerations in Light of COVID-19, 26 March 2020</a></li><li><a href="/resources/insights/200326-covid-19-liquidity-debt-incurrence-high-yield-bonds">COVID-19: Liquidity Issues and Debt Incurrence Capacity in High Yield Bonds, 26 March 2020</a></li><li><a href="/resources/insights/200323-covid-19-shareholder-proposals">Coronavirus (COVID-19) Considerations for Shareholder Proposals, 23 March  2020</a></li><li><a href="/resources/insights/200320-coronavirus-covid19-delays-filings">Coronavirus (COVID-19): How Delays in Processing of Filings May Impact Transactions, 20 March  2020</a></li><li><a href="/resources/insights/200319-covid-19-coronavirus-directors-checklist">COVID-19 (Coronavirus): A Practical Checklist for Directors, 19 March  2020</a></li><li><a href="/resources/insights/200318-sec-guidance-annual-meeting-changes-covid-19">SEC Guidance on Annual Meeting Changes Due to COVID-19, 18 March  2020</a></li><li><a href="/resources/insights/200317-public-disclosures-concerning-covid-19">What Companies Need to Know Now About Public Disclosures Concerning COVID-19, 17 March  2020</a></li><li><a href="/resources/insights/200316-covid-19-rule-10b5-1-plans-best-practices">COVID-19 and Rule 10b5-1 Plans: Best Practices, 16 March  2020</a></li><li><a href="/resources/insights/200225-disclosure-governance-hot-topics-public-companies-2020">Disclosure and Governance Hot Topics for Public Companies in 2020, 25 Feb  2020</a></li></ul><h4>Press + News</h4><ul><li><a href="/resources/insights/200401-virtual-oversights-tips">Practical Tips for Virtual Oversights (Article), 1 April 2020</a></li><li><a href="/resources/insights/200401-virtual-oversights-tips">So Your Company’s CEO Has Coronavirus. Does the World Have to Know? (Article), 25 March 2020</a></li><li><a href="/resources/news/200311-in-house-counsel-insider-trading-public-disclosure-covid-19">Why In-House Counsel Need to Watch for Insider Trading, Public Disclosure Issues From COVID-19 (Article), 11 March 2020</a></li></ul>

<p>Public Companies Counseling & Compliance Resources</p>

Public Companies Counseling & Compliance Resources